Esko is collaborating with Zacharon Pharmaceuticals, a San Diego - based biotechnology company, to develop
a commercial diagnostic assay for differentiating forms of MPS from urine and blood samples, a screening test for newborns and a tool for measuring the biochemical response of MPS patients to existing and novel therapies.
Dr. Manak has extensive expertise in development and validation of in - house and
commercial assays for HIV and related infectious diseases and their use in
diagnostic, epidemiological, vaccine and therapeutic programs.